Henry G. Watson

2.4k total citations
35 papers, 1.5k citations indexed

About

Henry G. Watson is a scholar working on Hematology, Internal Medicine and Surgery. According to data from OpenAlex, Henry G. Watson has authored 35 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 12 papers in Internal Medicine and 10 papers in Surgery. Recurrent topics in Henry G. Watson's work include Venous Thromboembolism Diagnosis and Management (12 papers), Hepatitis C virus research (7 papers) and Hemophilia Treatment and Research (7 papers). Henry G. Watson is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (12 papers), Hepatitis C virus research (7 papers) and Hemophilia Treatment and Research (7 papers). Henry G. Watson collaborates with scholars based in United Kingdom, United States and Belgium. Henry G. Watson's co-authors include David Keeling, Yen‐Lin Chee, Dominic Culligan, Peter Simmonds, J F Peutherer, Yen Lin Chee, Selma Rebus, F E Preston, Stuart Laidlaw and Μichael Μakris and has published in prestigious journals such as The Lancet, JAMA and The Journal of Infectious Diseases.

In The Last Decade

Henry G. Watson

35 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henry G. Watson United Kingdom 17 502 498 376 345 344 35 1.5k
Luigi Fenoglio Italy 14 215 0.4× 275 0.6× 244 0.6× 151 0.4× 142 0.4× 46 814
Carme Font Spain 23 502 1.0× 224 0.4× 262 0.7× 330 1.0× 34 0.1× 105 1.9k
Ken Ishikura Japan 18 329 0.7× 235 0.5× 123 0.3× 281 0.8× 23 0.1× 50 912
Erik A.M. Beckers Netherlands 26 223 0.4× 183 0.4× 147 0.4× 172 0.5× 18 0.1× 92 2.2k
Paul D. Mintz United States 24 86 0.2× 228 0.5× 127 0.3× 128 0.4× 32 0.1× 91 1.8k
Helen Savoia Australia 17 151 0.3× 196 0.4× 86 0.2× 141 0.4× 30 0.1× 45 1.1k
T. L. Simon United States 18 190 0.4× 155 0.3× 129 0.3× 116 0.3× 22 0.1× 34 1.2k
E D Thomas United States 9 59 0.1× 224 0.4× 231 0.6× 45 0.1× 77 0.2× 11 1.1k
Sudeep Shivakumar Canada 19 809 1.6× 365 0.7× 91 0.2× 522 1.5× 10 0.0× 64 1.2k
William McGehee United States 16 180 0.4× 192 0.4× 97 0.3× 173 0.5× 38 0.1× 24 973

Countries citing papers authored by Henry G. Watson

Since Specialization
Citations

This map shows the geographic impact of Henry G. Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry G. Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry G. Watson more than expected).

Fields of papers citing papers by Henry G. Watson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry G. Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry G. Watson. The network helps show where Henry G. Watson may publish in the future.

Co-authorship network of co-authors of Henry G. Watson

This figure shows the co-authorship network connecting the top 25 collaborators of Henry G. Watson. A scholar is included among the top collaborators of Henry G. Watson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry G. Watson. Henry G. Watson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martin, Jill, et al.. (2023). Fibrinogenolysis and fibrinolysis in vaccine-induced immune thrombocytopenia and thrombosis. Journal of Thrombosis and Haemostasis. 21(12). 3589–3596. 5 indexed citations
2.
Watson, Henry G., et al.. (2023). Venous thromboembolism risk following temporary immobilisation after injury: evaluation of the Aberdeen VTE risk tool. Emergency Medicine Journal. 40(5). 361–368. 1 indexed citations
3.
Whyte, Claire S., Gael B. Morrow, Carol Wallace, et al.. (2022). The suboptimal fibrinolytic response in COVID‐19 is dictated by high PAI‐1. Journal of Thrombosis and Haemostasis. 20(10). 2394–2406. 39 indexed citations
4.
Mutch, Nicola J., et al.. (2010). Model thrombi formed under flow reveal the role of factor XIII‐mediated cross‐linking in resistance to fibrinolysis. Journal of Thrombosis and Haemostasis. 8(9). 2017–2024. 61 indexed citations
5.
Watson, Henry G. & Yen Lin Chee. (2008). Aspirin and other antiplatelet drugs in the prevention of venous thromboembolism. Blood Reviews. 22(2). 107–116. 28 indexed citations
6.
Watson, Henry G. & M. Greaves. (2008). Can We Predict Bleeding?. Seminars in Thrombosis and Hemostasis. 34(1). 97–103. 48 indexed citations
7.
Keeling, David, et al.. (2006). The management of heparin‐induced thrombocytopenia. British Journal of Haematology. 133(3). 259–269. 113 indexed citations
8.
Toff, William D., Chris I. Jones, I. Ford, et al.. (2006). Effect of Hypobaric Hypoxia, Simulating Conditions During Long-Haul Air Travel, on Coagulation, Fibrinolysis, Platelet Function, and Endothelial Activation. JAMA. 295(19). 2251–2251. 98 indexed citations
9.
Chee, Yen‐Lin, Dominic Culligan, & Henry G. Watson. (2001). Inferior vena cava malformation as a risk factor for deep venous thrombosis in the young. British Journal of Haematology. 114(4). 878–880. 169 indexed citations
10.
Watson, Henry G., Trevor Baglin, Stuart Laidlaw, Μichael Μakris, & F E Preston. (2001). A comparison of the efficacy and rate of response to oral and intravenous Vitamin K in reversal of over‐anticoagulation with warfarin. British Journal of Haematology. 115(1). 145–149. 149 indexed citations
11.
Robbie, L. A., Susan A. Berry, Nuala A. Booth, et al.. (2000). Myeloid leukaemic cells can lyse fibrin directly. British Journal of Haematology. 111(2). 524–529. 1 indexed citations
12.
Chee, Yen Lin, et al.. (2000). Sight‐threatening varicella zoster virus infection after fludarabine treatment. British Journal of Haematology. 110(4). 874–875. 3 indexed citations
13.
Watson, Henry G., et al.. (1995). Absence of hepatitis A virus transmission by high‐purity solvent detergent treated coagulation factor concentrates in Scottish haemophiliacs. British Journal of Haematology. 89(1). 214–216. 2 indexed citations
14.
Watson, Henry G., et al.. (1994). Virus‐associated haemophagocytic syndrome: further evidence for a T‐cell mediated disorder. British Journal of Haematology. 86(1). 213–215. 22 indexed citations
15.
Jarvis, Lisa, et al.. (1994). Frequent Reinfection And Reactivation Of Hepatitis C Virus Genotypes In Multitransfused Hemophiliacs. The Journal of Infectious Diseases. 170(4). 1018–1022. 112 indexed citations
16.
Watson, Henry G., Selma Rebus, Peter Simmonds, J F Peutherer, & C A Ludlam. (1993). HEPATITIS-B VIRUS - A LONGITUDINAL-STUDY OF SEROLOGICAL RESPONSES AND DNA DETECTION IN MULTITRANSFUSED HEMOPHILIACS AND COAGULATION-FACTOR CONCENTRATES. Thrombosis and Haemostasis. 69. 1282–1282. 2 indexed citations
17.
Watson, Henry G. & Christopher A. Ludlam. (1992). Immunological abnormalities in haemophiliacs. Blood Reviews. 6(1). 26–33. 11 indexed citations
18.
Simmonds, Peter, Selma Rebus, G. Leadbetter, et al.. (1990). Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug users. The Lancet. 336(8729). 1469–1472. 185 indexed citations
19.
Watson, Henry G.. (1976). Clinical Cardiovascular Physiology. BMJ. 2(6030). 306.2–306. 43 indexed citations
20.
FREUD, G. E., et al.. (1975). Activation of the hypertrophic right ventricle in the dog. Cardiovascular Research. 9(3). 302–313. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luigi Fenoglio Breakdown of academic impact, for papers by Carme Font Breakdown of academic impact, for papers by Ken Ishikura Breakdown of academic impact, for papers by Erik A.M. Beckers Breakdown of academic impact, for papers by Paul D. Mintz Breakdown of academic impact, for papers by Helen Savoia Breakdown of academic impact, for papers by T. L. Simon Breakdown of academic impact, for papers by E D Thomas Breakdown of academic impact, for papers by Sudeep Shivakumar Breakdown of academic impact, for papers by William McGehee
Rankless by CCL
2026